News

Doctors with special licenses no longer need to use special prescription pads, called yellow prescriptions (Rx) because of ...
Doctors with special licenses no longer need to use special prescription pads that are difficult to obtain for their patients ...
A “bad batch” of drugs was suspected in the overdoses of 27 people in Baltimore. What are bad batches and where do they come ...
Navigating 2025 Drug Pricing Policies webinar, panelists discussed the Most Favored Nation executive order, bills aimed at ...
Merck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its investigational, once-daily, oral, two-drug, single-tablet regimen of ...
Despite the Trump administration’s efforts to shrink the FDA, Senate appropriators unanimously advanced a funding bill ...
The latest episode of Prescription for Life is out on WKYC+, and while you're soaking up the summer sun we have a few reminders how not to get burned by the heat.
A large U.S. medical records study has found that adults prescribed gabapentin six or more times for chronic low back pain ...
Kandiyohi County Sheriff Eric Tollefson agrees with a lawsuit delaying a new law that demands jailers give inmates the same ...
They were designed to treat diabetes, then prescribed for weight loss, and now—as researchers are finding—they might hold the ...
The Food and Drug Administration (FDA) has accepted the New Drug Application for doravirine/islatravir (DOR/ISL) for adults with virologically-suppressed HIV-1 infection.
Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.